Current Status of Thalassemia in Lao People's Democratic Republic.

Alongkone Phengsavanh, Sourideth Sengchanh, Chanthala Souksakhone, Boupalisone Souvanlasy, Vanphanom Sychareun

Journal: Hemoglobin 2022;46(1):58-61

PMID: 35950579

Abstract

Thalassemia is a major public health and economical burden in Lao People's Democratic Republic (Lao PDR). This study is aiming to elaborate the current situation of Thalassemia in Laos. α- and β-thalassemia (α- and β-thal) includes the common Hb S (: c.20A>T) and hemoglobins (Hbs) such as Hb Constant Spring (Hb CS or : c.427T>C) and Hb E (: c.79G>A) that are prevalent in the country. Overall, the prevalence of α-thal in Lao PDR is 26.8%. There was high prevalence of homozygous (12.8%) and heterozygous (39.7%) Hb E among migrant workers from Lao PDR who crossed the border to work in Thailand. Iron chelation, blood transfusion, prenatal screening and diagnosis, comprehensive treatment are still the major problems. Splenectomy is still performed. A national registry has still not been established. This is a national economic burden for the country. Thalassemia prevention and control strategy should be established and advocated by the government in order to reduce morbidity and premature mortality.

Address: Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Health Sciences, Vientiane, Lao People's Democratic Republic.; Department of Paediatrics, Faculty of Medicine, University of Health Sciences, Vientiane, Lao People's Democratic Republic.; Department of administration, Blood Donation Centre, Laos Red Cross, Vientiane, Lao People's Democratic Republic.; Department of Pediatrics Hematology, National Children Hospital, Vientiane, Lao People's Democratic Republic.; Department of Health promotion, Faculty of Public Health, University of Health Sciences, Vientiane, Lao People's Democratic Republic.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.